Novabay (NBY) Gains in Pre-Market Trading for June 23

Equities Staff  |

Novabay Pharmaceuticals Inc (NYSE:NBY) has already risen $0.0104 in early trading Thursday.

After closing the previous trading session at $0.20, Novabay has moved 5.29% higher ahead of market open.

The company is down 4.98% over the last 5 days.

Today could shape up to be an interesting day for Novabay investors.

For technical charts, analysis, and more on Novabay Pharmaceuticals Inc visit the company profile.

Pre-market prices and movements as of 08:15:36 est.

About Novabay Pharmaceuticals Inc

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focusing high-quality, differentiated, anti-infective consumer products: Avenova®, the premier antimicrobial lid and lash spray, CelleRx® Clinical Reset, a breakthrough product in the beauty category, and NeutroPhase® Skin and Wound Cleanser for wound healing. NovaBay's products are formulated with its patented, pure, stable, pharmaceutical-grade hypochlorous acid that replicates the antimicrobial chemicals used by white blood cells to fight infection. NovaBay's hypochlorous acid products do not cause stinging or irritation, are non-toxic and non-sensitizing, making them completely safe for regular use. Avenova is the only commercial hypochlorous acid lid and lash spray product clinically proven to reduce bacterial load on ocular skin surfaces, thus effectively addressing the underlying cause of bacterial dry eye.

To get more information on Novabay Pharmaceuticals Inc and to follow the company's latest updates, you can visit the company's profile page here: Novabay Pharmaceuticals Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

The Best Laid Plans of Mice and Men — Part II
Why I’m Buying the 'New' Value Stocks
Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade



Market Movers

Sponsored Financial Content